Kenvue Inc. (KVUE) Prepares for $3.5 Billion IPO Spin-Off, Marking Johnson & Johnson’s Strategic Consumer Health Breakaway
Kenvue Inc., the newly independent consumer health company spun off from Johnson & Johnson, is gearing up for a $3.5 billion initial public offering...
GRAIL, Inc. (GRAL) Files for Landmark $500 Million IPO to Accelerate Multi-Cancer Early Detection Expansion
GRAIL, Inc., a Menlo Park–based leader in cancer diagnostics, has filed for a $500 million initial public offering (IPO) expected to debut on the...
Praxis Precision Medicines (PRAX) Readies Secondary IPO to Fund Late-Stage Neurology Drug Pipeline
Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a Boston-based biotechnology firm focused on treating central nervous system (CNS) disorders, is preparing a secondary public offering...
Hillenbrand, Inc. (HI) Eyes Strategic IPO Spin-Off to Unlock Value in Specialty Industrial Machinery Market
Hillenbrand, Inc. (HI), a global leader in specialty industrial machinery, is reportedly preparing for a strategic IPO spin-off in mid-2026, aiming to raise approximately...
Ericsson Eyes Landmark IPO for Enterprise Cloud Unit Amid 5G and AI Infrastructure Boom
Telefonaktiebolaget LM Ericsson (publ), the Swedish telecommunications giant, is reportedly preparing to spin off and list its Enterprise Cloud division in a high-profile IPO...
